BIO Stock Ownership Activity

BIO-RAD LABORATORIES-A 13F holders

3 value investing gurus have made changes to the BIO-RAD LABORATORIES-A (BIO) position according to the gurus' latest SEC quarterly report(s). BIO has been bought (as a new position) by 1 guru(s), the number of BIO shares has been increased by 2 super investor(s).

Which gurus or hedge funds are buying BIO now?

According to the latest SEC filing(s) BIO-RAD LABORATORIES-A (BIO) has been bought by 3 gurus: Mason Hawkins - Longleaf Partners (added shares +14.53%), Parnassus Investments - Parnassus Endeavor Fund (added shares +7.7%) and Nathaniel Simons - Meritage Group (new buy).

To see more about who is investing in BIO-RAD LABORATORIES-A (BIO), please go to the BIO ownership page.

History
Name
Company
%
Activity
Share
Change
% change to
Portfolio
% of
Portfolio
2023 Q4 (3 results)
Nathaniel Simons
Meritage Group
buy
+817
+0.01%
0.01%
Mason Hawkins
Longleaf Partners
+14.53%
+24,982
+0.68%
5.33%
Parnassus Investments
Parnassus Endeavor Fund
+7.70%
+16,999
+0.11%
1.56%
Current price: $279.91 13.33% AVG reported price*: $322.97
2023 Q3 (3 results)
Mason Hawkins
Longleaf Partners
buy
+100,612
+5.02%
2.94%
Parnassus Investments
Parnassus Endeavor Fund
buy
+217,479
+1.74%
1.72%
Nathaniel Simons
Meritage Group
-100.00%
-640
-0.01%
0.00%
Current price: $279.91 21.91% AVG reported price*: $358.45
2023 Q2 (1 result)
Nathaniel Simons
Meritage Group
buy
+640
+0.01%
0.00%
Current price: $279.91 26.05% Reported price*: $378.52
2022 Q3 (1 result)
Nathaniel Simons
Meritage Group
-100.00%
-469
-0.01%
0.00%
Current price: $279.91 43.41% Reported price*: $494.67
2022 Q2 (1 result)
Nathaniel Simons
Meritage Group
-40.86%
-324
-0.00%
0.00%
Current price: $279.91 43.41% Reported price*: $494.67
2022 Q1 (1 result)
Nathaniel Simons
Meritage Group
-22.41%
-229
-0.00%
0.01%
Current price: $279.91 50.34% Reported price*: $563.68
2021 Q4 (1 result)
Nathaniel Simons
Meritage Group
+124.12%
+367
+0.01%
0.01%
Current price: $279.91 62.96% Reported price*: $755.72
2021 Q3 (1 result)
Nathaniel Simons
Meritage Group
-47.65%
-415
-0.01%
0.01%
Current price: $279.91 62.46% Reported price*: $745.61
2021 Q2 (1 result)
Nathaniel Simons
Meritage Group
+19.48%
+142
+0.00%
0.01%
Current price: $279.91 56.54% Reported price*: $644.09
2021 Q1 (1 result)
Nathaniel Simons
Meritage Group
+8.48%
+57
+0.00%
0.01%
Current price: $279.91 50.95% Reported price*: $570.64
2020 Q4 (1 result)
Nathaniel Simons
Meritage Group
-11.70%
-89
-0.00%
0.01%
Current price: $279.91 52.02% Reported price*: $583.33
2020 Q3 (1 result)
Nathaniel Simons
Meritage Group
buy
+761
+0.01%
0.01%
Current price: $279.91 45.66% Reported price*: $515.11
2018 Q3 (1 result)
James Crichton
Hitchwood Capital Management
-100.00%
-81,993
-0.92%
0.00%
Current price: $279.91 2.99% Reported price*: $288.54
2018 Q2 (1 result)
James Crichton
Hitchwood Capital Management
-45.34%
-68,007
-1.21%
0.00%
Current price: $279.91 2.99% Reported price*: $288.54
2018 Q1 (1 result)
James Crichton
Hitchwood Capital Management
-64.29%
-270,000
-4.07%
2.26%
Current price: $279.91 11.93% Reported price*: $250.08
2017 Q4 (1 result)
James Crichton
Hitchwood Capital Management
+20.00%
+70,000
+0.63%
3.76%
Current price: $279.91 17.28% Reported price*: $238.67
2017 Q3 (1 result)
James Crichton
Hitchwood Capital Management
-12.50%
-50,000
-0.47%
3.32%
Current price: $279.91 25.96% Reported price*: $222.22
2017 Q2 (1 result)
James Crichton
Hitchwood Capital Management
+33.33%
+100,000
+0.93%
3.72%
Current price: $279.91 23.68% Reported price*: $226.31
2017 Q1 (1 result)
James Crichton
Hitchwood Capital Management
buy
+300,000
+2.28%
2.28%
Current price: $279.91 40.42% Reported price*: $199.34
23 of 23

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.